Back to News
Market Impact: 0.2
Glucotrack Announces $11.5 Million Financing
Source: businesswire.com
Healthcare & BiotechPrivate Markets & VentureCompany Fundamentals
Glucotrack announced $11.5 million in convertible-note financing, comprising new capital and the rollover of existing notes. The funding is intended to support the healthcare technology company's strategic growth, though no operating targets, valuation, or financing terms were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
GCTK0.45
More News
- Microsoft offers buyouts to nearly 30% of workforce in ongoing AI shift
- From Wall Street to Silicon Valley, Anthropic IPO poised to have massive 'trickle-down effect'
- Anthropic’s IPO filing shows explosive growth, risks and staggering costs
- Meta announces $95 billion stock offering to fund AI expansion
- Elon Musk warns more than 200 AI cloud companies face ‘guppy-level death’ as the AI boom runs into a debt crisis
- HSBC Announces $1 Billion Buyback After Profit Growth Misses